Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma

Human Pathology

Volumn 27, Issue 3, 1996, Pages 225-233

  Nakamura, Shotaro ^a   Akazawa, Kouhei ^a   Kinukawa, Naoko ^a   Yao, Takashi ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

bcl 28; gastric lymphoma; mucosa associated lymphoid tissue; p53

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PROGNOSIS; PROTEIN EXPRESSION; STOMACH LYMPHOMA;

EID: 0029969414     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90061-1     Document Type: Article

References (40)

1. Tsujimoto Y, Cossman J, Jaffe E, et al: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443, 1985
2. H on chromosome 14 and near a transcriptional unit on 18. Cell 41:899-906, 1985
3. Cleary ML, Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A 82:7439-7443, 1985
4. Vaux DL, Gory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988
5. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
6. Pezzella F, Tse AGD, Cordell JL, et al: Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am J Pathol 137:225-232, 1990
7. Gaulard P, d'Agay M-F, Peuchmaur M, et al: Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 140:1089-1095, 1992
8. Kondo E, Yoshino T, Yamadori I, et al: Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol 145:330-337, 1994
9. Kolodziejczyk P, Yao T, Oya M, et al: Long term follow-up study of patients with gastric adenomas with malignant transformation. Cancer 74:2896-2907, 1994
10. Leek RD, Kaklamanis L, Pezzella F, et al: bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69:135-139, 1994
11. Hockenbery DM, Zutter M, Hickey W, et al: BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Nad Acad Sci U S A 88:6961-6965, 1991
12. Isaacson PG, Wotherspoon AC, Diss TC, et al: bcl-2 expression in lymphomas. Lancet 337:175-176, 1991
13. Villuendas R, Piris MA, Orradre JL, et al: Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue. Am J Pathol 139:989-993, 1991
14. Ashton-Key M, Biddolph SC, Stein H, et al: Heterogeneity of bcl-2 expression in MALT lymphoma. Histopathology 26:75-78, 1995
15. LeBrun DP, Kamel OW, Cleary ML, et al: Follicular lymphomas of the gastrointestinal tract: Pathologic features in 31 cases and bcl-2 oncogenic protein expression. Am J Pathol 140:1327-1335, 1992
16. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453-456, 1991
17. Said JW, Barrera R, Shintaku IP, et al: Immunohistochemical analysis of p53 expression in malignant lymphomas. Am J Pathol 141:1343-1348, 1992
18. Cesarman E, Inghirami G, Chadburn A, et al: High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. AmJ Pathol 143:845-856, 1993
19. Pezzella F, Morrison H, Jones M, et al: Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 22:39-44, 1993
20. Xerri L, Bouabdallah R, Camerlo J, et al: Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data. HUM PATHOL 25:449-454, 1994
21. Yonish-Rouach E, Resnitzky D, Lotem J, et al: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347, 1991
22. Silvestrini R, Veneroni S, Daidone MG, et al: The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499-504, 1994
23. Nakamura S, Akazawa K, Yao T, et al: Primary gastric lyphoma: A clinico pathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 76:1313-1324, 1995
24. Weingrad DN, Decosse JJ, Sherlock P, et al: Primary gastrointestinal lymphoma: A 30-year review. Cancer 49:1258-1265, 1982
25. Isaacson PG, Spencer J, Wright DH: Classifying primary gut lymphomas. Lancet 2:1148-1149, 1988
26. Isaacson PG: Gastrointestinal lymphoma. HUM PATHOL 25:1020-1029, 1994
27. Castrillo JM, Montalban C, Obeso G, et al: Gastric B-cell mucosa associated lymphoid tissue lymphoma: A clinicopathological study in 56 patients. Gut 33:1307-1311, 1992
28. Stansfeld AG, Diebold J, Kapanci Y, et al: Updated Kiel classification for lymphomas. Lancet 1:292-293 603, 1988
29. Mielke PW: Goodman-Kruskal tau and gamma, in Kotz S, Johnson NL (eds): Encyclopedia of Statistical Sciences, vol 3. New York, NY, Wiley, 1983, pp 446-448
30. 2 tests. Biometrics 10:417-441, 1954
31. Pezzella F, Gatter KC, Mason DY, et al: Bcl-2 protein expression in follicular lymphomas in absence of 14; 18 translocation. Lancet 336:1510-1511, 1990
32. Pan L, Diss TC, Cunningham D, et al: The bcl-2 gene in primary B cell lymphoma of mucosa-associated lymphoid tissue (MALT). Am J Pathol 135:7-11, 1989
33. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
34. Allred DC, Clark GM, Elledge R, et al: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200-206, 1993
35. Pezzella F, Turley H, Kuzu I, et al: bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
36. Piris MA, Pezella F, Martinez-Montero JC, et al: p53 and bcl-2 expression in high-grade B-cell lymphomas: Correlation with survival time. Br J Cancer 69:337-341, 1994
37. Shimaya K, Shiozaki H, Inoue M, et al: Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch [A] 422:271-276, 1993
38. Brambilla E, Gazzeri S, Moro D, et al: Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol 143:199-210, 1993
39. DiGiuseppe JA, Hruban RH, Goodman SN, et al: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 101:684-688, 1994
40. Battifora H: p53 immunohistochemistry: A word of caution. HUM PATHOL 25:435-437, 1994